Yasunori Emi

2.9k total citations
116 papers, 2.2k citations indexed

About

Yasunori Emi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yasunori Emi has authored 116 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Yasunori Emi's work include Colorectal Cancer Treatments and Studies (56 papers), Gastric Cancer Management and Outcomes (49 papers) and Cancer Treatment and Pharmacology (26 papers). Yasunori Emi is often cited by papers focused on Colorectal Cancer Treatments and Studies (56 papers), Gastric Cancer Management and Outcomes (49 papers) and Cancer Treatment and Pharmacology (26 papers). Yasunori Emi collaborates with scholars based in Japan, United States and Switzerland. Yasunori Emi's co-authors include Yoshihiko Maehara, Yoshihiro Kakeji, Eiji Oki, Shunji Kohnoe, Ikuo Takahashi, Keizō Sugimachi, Hideo Baba, Hiroshi Saeki, Beverly A. Teicher and Akihiro Watanabe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Yasunori Emi

114 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasunori Emi Japan 28 917 906 694 546 256 116 2.2k
Naoki Muguruma Japan 23 687 0.7× 544 0.6× 635 0.9× 469 0.9× 269 1.1× 161 1.9k
Esther Endlicher Germany 23 684 0.7× 627 0.7× 682 1.0× 234 0.4× 249 1.0× 61 1.6k
Hei‐Cheul Jeung South Korea 31 1.2k 1.3× 1.2k 1.3× 687 1.0× 868 1.6× 385 1.5× 138 2.8k
Katsunobu Oyama Japan 27 669 0.7× 650 0.7× 627 0.9× 649 1.2× 237 0.9× 122 2.1k
Tomoya Yokota Japan 31 1.4k 1.5× 1.4k 1.6× 1.1k 1.6× 799 1.5× 179 0.7× 186 3.3k
Tomoharu Miyashita Japan 24 499 0.5× 708 0.8× 677 1.0× 725 1.3× 256 1.0× 154 2.2k
Chueh‐Chuan Yen Taiwan 23 708 0.8× 1.2k 1.3× 821 1.2× 541 1.0× 52 0.2× 57 2.3k
Eric T. Kimchi United States 27 504 0.5× 1.1k 1.2× 440 0.6× 588 1.1× 94 0.4× 103 2.1k
Tsutomu Namikawa Japan 24 1.1k 1.2× 743 0.8× 1.1k 1.6× 195 0.4× 342 1.3× 235 2.3k
Jing Huang China 22 655 0.7× 1.1k 1.2× 546 0.8× 581 1.1× 67 0.3× 110 2.2k

Countries citing papers authored by Yasunori Emi

Since Specialization
Citations

This map shows the geographic impact of Yasunori Emi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasunori Emi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasunori Emi more than expected).

Fields of papers citing papers by Yasunori Emi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasunori Emi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasunori Emi. The network helps show where Yasunori Emi may publish in the future.

Co-authorship network of co-authors of Yasunori Emi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasunori Emi. A scholar is included among the top collaborators of Yasunori Emi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasunori Emi. Yasunori Emi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Takao, Kazuyuki Ishida, Yasunori Emi, et al.. (2022). Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial. Cancers. 14(18). 4392–4392. 2 indexed citations
2.
Iguchi, Tomohiro, Norifumi Iseda, Kazuki Takada, et al.. (2022). A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report. SHILAP Revista de lepidopterología. 8(1). 19–19.
3.
Ninomiya, Mizuki, Yasunori Emi, Takashi Motomura, et al.. (2021). Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases. International Journal of Clinical Oncology. 26(12). 2255–2264. 14 indexed citations
4.
Oki, Eiji, Yasunori Emi, Takeharu Yamanaka, et al.. (2019). Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). British Journal of Cancer. 121(3). 222–229. 37 indexed citations
5.
Oki, Eiji, Takeshi Kato, Hideaki Bando, et al.. (2018). A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study. Clinical Colorectal Cancer. 17(2). 147–155. 32 indexed citations
6.
Oki, Eiji, Akihiko Murata, Kazuhiro Yoshida, et al.. (2016). A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC). Annals of Oncology. 27(7). 1266–1272. 32 indexed citations
7.
Miyamoto, Yuji, Akihito Tsuji, Hiroaki Tanioka, et al.. (2016). S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102). International Journal of Clinical Oncology. 21(4). 705–712. 6 indexed citations
8.
Nitta, Hidetoshi, Takayuki Shimose, Yasunori Emi, et al.. (2016). Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes. Medical Oncology. 33(11). 118–118. 20 indexed citations
9.
Oki, Eiji, Shoji Tokunaga, Yasunori Emi, et al.. (2015). Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer. 19(3). 968–976. 95 indexed citations
10.
Oki, Eiji, Yasunori Emi, Yoshito Akagi, et al.. (2013). Phase II Trial of Alternating mFOLFOX6 and FOLFIRI Regimens in the First-Line Treatment for Unresectable or Metastatic Colorectal Cancer (KSCC0701). Oncology. 84(4). 233–239. 7 indexed citations
11.
Beppu, Toru, Yasunori Emi, Yoshihiro Kakeji, et al.. (2012). Liver resectability following mFOLFOX6 with bevacizumab as the first-line treatment of unresectable liver limited metastases from colorectal cancer in Japanese patients (KSCC 0802).. Journal of Clinical Oncology. 30(4_suppl). 666–666. 2 indexed citations
12.
Takahashi, Ikuo, Yasunori Emi, Yoshihiro Kakeji, et al.. (2005). Increased Antitumor Activity in Combined Treatment TS-1 and Docetaxel. Oncology. 68(2-3). 130–137. 22 indexed citations
13.
Emi, Yasunori, Kaoru Kitamura, Yasunori Shikada, et al.. (2002). Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis. Surgery. 131(1). S217–S221. 32 indexed citations
14.
Orita, Hiroyuki, Yoshihiko Maehara, Yasunori Emi, et al.. (1997). c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.. PubMed. 44(13). 294–8. 24 indexed citations
15.
Holden, Sylvia A., et al.. (1997). Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants. Cancer Chemotherapy and Pharmacology. 40(1). 87–93. 11 indexed citations
16.
Teicher, Beverly A., Yasunori Emi, Yoshihiro Kakeji, & David Northey. (1996). TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy. European Journal of Cancer. 32(14). 2461–2466. 36 indexed citations
17.
Teicher, Beverly A., Gulshan Ara, Yasunori Emi, et al.. (1996). RSR13: Effects on tumor oxygenation and response to therapy. Drug Development Research. 38(1). 1–11. 6 indexed citations
18.
Maehara, Yoshihiko, Akihiro Watanabe, Y. Kakeji, et al.. (1992). Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. British Journal of Cancer. 65(3). 417–420. 19 indexed citations
19.
Emi, Yasunori, Shunji Kohnoe, Motofumi Yoshida, et al.. (1992). Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans. Cancer. 70(5). 1177–1182. 4 indexed citations
20.
Maehara, Yoshihiko, Yasunori Emi, Tamon Kusumoto, et al.. (1990). Estrogen-Receptor-Negative Breast Cancer Tissue Is Chemosensitive in vitro Compared with Estrogen-Receptor-Positive Tissue. European Surgical Research. 22(1). 50–56. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026